Michael Nawrath


Last quote by Michael Nawrath

The example of Rituxan in Europe shows the significant negative impact of biosimilars, and that's going to be accentuated in the fourth quarter.feedback
share this quote
Oct 19 2017
We can learn a lot about a person if we know what types of things he or she talks about or comments on the most frequently. There are numerous topics with which Michael Nawrath is associated, including Novartis, Actelion, and result. Most recently, Michael Nawrath has been quoted saying: “Beyond the sales losses through biosimilars, hundreds of millions in royalties will evaporate. Roche faces a double whammy as it becomes a net payer of royalties.” in the article 'Double whammy' for Roche as manufacturing patent losses loom. An other article where Michael Nawrath has been quoted is Novartis heart drug success opens up new care option.
Automatically powered by Storyzy
Take our quote verification challenge and find out !

Quotes by Michael Nawrath

Quote Verifier
Check if the quote you read on social networks is authentic
This webpage has been created by a robot: errors and absent quotes cannot be totally avoided

Quote :

Mistake :

Comments :